Five-Year Clinical and Angiographic Outcomes of a Randomized Comparison of Sirolimus-Eluting and Paclitaxel-Eluting Stents: Results of the Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization LATE Trial, Circulation, vol.123, issue.24, pp.2819-2828, 2011. ,
DOI : 10.1161/CIRCULATIONAHA.110.004762
Stent Thrombosis: Incidence, Predictors and New Technologies, Thrombosis, vol.7, issue.7, pp.1-12, 2012. ,
DOI : 10.1016/j.jacc.2011.05.050
URL : http://doi.org/10.1155/2012/956962
Five-year clinical outcomes of sirolimus-eluting versus paclitaxel-eluting stents in high-risk patients, Catheterization and Cardiovascular Interventions, vol.119, issue.4, pp.494-501, 2011. ,
DOI : 10.1002/ccd.22757
Morphologic changes in infarct-related plaque after coronary stent placement: a serial angioscopy study, ACC Current Journal Review, vol.13, issue.3, pp.1558-1565, 2003. ,
DOI : 10.1016/j.accreview.2004.02.052
Neointimal coverage of stents in human coronary arteries observed by angioscopy, Journal of the American College of Cardiology, vol.23, issue.2, pp.341-346, 1994. ,
DOI : 10.1016/0735-1097(94)90417-0
Drug-Eluting Stent and Coronary Thrombosis: Biological Mechanisms and Clinical Implications, Circulation, vol.115, issue.8, p.17325255, 2007. ,
DOI : 10.1161/CIRCULATIONAHA.106.675934
Sirolimus-and taxol-eluting stents differ towards intimal hyperplasia and re-endothelialization, The Journal of Invasive Cardiology, vol.17, pp.497-502, 2005. ,
Vascular Responses to Drug Eluting Stents: Importance of Delayed Healing, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.27, issue.7, pp.1500-1510, 2007. ,
DOI : 10.1161/ATVBAHA.107.144220
Inhibitory Effect of Paclitaxel on Endothelial Cell Adhesion and Migration, Pharmacology, vol.85, issue.3, pp.136-145, 2010. ,
DOI : 10.1159/000280587
Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study, The Lancet, vol.369, issue.9562, pp.667-678, 2007. ,
DOI : 10.1016/S0140-6736(07)60314-6
Modeling the transport of drugs eluted from stents: physical phenomena driving drug distribution in the arterial wall, Biomechanics and Modeling in Mechanobiology, vol.4, issue.2, pp.327-347, 2014. ,
DOI : 10.1007/s10237-013-0546-4
URL : https://hal.archives-ouvertes.fr/hal-01048584
Robust optimization of cardiovascular stents: a comparison of methods, Engineering Optimization, vol.1993, issue.2, pp.207-217, 1080. ,
DOI : 10.1214/ss/1177012413
Studies on Design Optimization of Coronary Stents, Journal of Medical Devices, vol.2, issue.1, 2008. ,
DOI : 10.1115/1.2885145
Optimization of Cardiovascular Stent Design Using Computational Fluid Dynamics, Journal of Biomechanical Engineering, vol.134, issue.1, p.22482657, 2012. ,
DOI : 10.1115/1.4005542
Identification of Hemodynamically Optimal Coronary Stent Designs Based on Vessel Caliber, IEEE Transactions on Biomedical Engineering, vol.59, issue.7, p.22547450, 1992. ,
DOI : 10.1109/TBME.2012.2196275
Finite Element Shape Optimization for Biodegradable Magnesium Alloy Stents, Annals of Biomedical Engineering, vol.30, issue.9, pp.2829-2840, 2010. ,
DOI : 10.1007/s10439-010-0057-8
Stented artery biomechanics and device design optimization, Medical & Biological Engineering & Computing, vol.27, issue.3, pp.505-513, 2007. ,
DOI : 10.1007/s11517-007-0180-3
Multiobjective design optimisation of coronary stents, Biomaterials, vol.32, issue.31, pp.7755-7773, 2011. ,
DOI : 10.1016/j.biomaterials.2011.07.059
Geometry parameterization and multidisciplinary constrained optimization of coronary stents, Biomechanics and Modeling in Mechanobiology, vol.198, issue.45???46, pp.61-82, 2012. ,
DOI : 10.1007/s10237-011-0293-3
A taxonomy of global optimization methods based on response surfaces, Journal of Global Optimization, vol.21, issue.4, pp.345-383, 2001. ,
DOI : 10.1023/A:1012771025575
Optimizing the design of a bioabsorbable metal stent using computer simulation methods, Biomaterials, vol.34, issue.33, pp.8049-8060, 2013. ,
DOI : 10.1016/j.biomaterials.2013.07.010
The effect of variable release kinetics on paclitaxel efficacy from a drug eluting stent in a porcine model, EuroIntervention, vol.1, pp.228-235, 2005. ,
Adjustable paclitaxel release kinetics and its efficacy to inhibit smooth muscle cells proliferation, Journal of Controlled Release, vol.130, issue.1, pp.9-14, 2008. ,
DOI : 10.1016/j.jconrel.2008.05.008
Endothelialization of sirolimus-eluting stents with slow and extended drug release in the porcine overstretch model, The Journal of Invasive Cardiology, vol.20, pp.631-634, 2008. ,
Preparation and in vitro release profiles of drug-eluting controlled biodegradable polymer coating stents, Colloids and Surfaces B: Biointerfaces, vol.73, issue.2, pp.199-206, 2009. ,
DOI : 10.1016/j.colsurfb.2009.05.016
Impact of Drug Release Kinetics on Vascular Response to Different Zotarolimus-Eluting Stents Implanted in Patients With Long Coronary Stenoses, JACC: Cardiovascular Interventions, vol.4, issue.7, pp.778-785, 2011. ,
DOI : 10.1016/j.jcin.2011.04.007
Intravascular drug release kinetics dictate arterial drug deposition, retention, and distribution, Journal of Controlled Release, vol.123, issue.2, pp.100-108, 2007. ,
DOI : 10.1016/j.jconrel.2007.06.025
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2702153
Stent elution rate determines drug deposition and receptor-mediated effects, Journal of Controlled Release, vol.161, issue.3, pp.918-926, 2012. ,
DOI : 10.1016/j.jconrel.2012.05.039
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616625
Release profiles in drug-eluting stents: Issues and uncertainties, Journal of Controlled Release, vol.120, issue.3, pp.149-160, 2007. ,
DOI : 10.1016/j.jconrel.2007.04.022
Drug Release Kinetics From Stent Device-Based Delivery Systems, Journal of Cardiovascular Pharmacology, vol.51, issue.2, pp.118-125, 2008. ,
DOI : 10.1097/FJC.0b013e318158540f
Applications on Multi-Dimensional Sphere Packings: Derivative-Free Optimization, 2011. ,
New horizons in sphere-packing theory, part II: lattice-based derivative-free optimization via global surrogates, Journal of Global Optimization, vol.199, issue.39, pp.1-31, 2012. ,
DOI : 10.1007/s10898-012-9866-7
Diffusion-limited binding explains binary dose response for local arterial and tumour drug delivery, Cell Proliferation, vol.22, issue.3, pp.348-363, 2009. ,
DOI : 10.1111/j.1365-2184.2009.00602.x
Coronary Stents, Journal of the American College of Cardiology, vol.56, issue.10, pp.1-42, 2010. ,
DOI : 10.1016/j.jacc.2010.06.007
Inflammation in atherosclerosis, Nature, vol.103, issue.6917, pp.868-874, 2002. ,
DOI : 10.1074/jbc.274.45.32048
Numerical simulation of mass transfer in porous media of blood vessel walls, Advanced Drug Delivery Reviews, vol.273, pp.464-477, 1997. ,
SUNDIALS, ACM Transactions on Mathematical Software, vol.31, issue.3, 2005. ,
DOI : 10.1145/1089014.1089020
Multiscale Boundary Conditions for Drug Release from Cardiovascular Stents, Multiscale Modeling & Simulation, vol.7, issue.2, pp.565-588, 2008. ,
DOI : 10.1137/07070214X
Higuchi equation: Derivation, applications, use and misuse, International Journal of Pharmaceutics, vol.418, issue.1, pp.6-12, 2011. ,
DOI : 10.1016/j.ijpharm.2011.03.051
Examination of the In Vivo Mechanisms of Late Drug-Eluting Stent Thrombosis, JACC: Cardiovascular Interventions, vol.5, issue.1, pp.12-20, 2012. ,
DOI : 10.1016/j.jcin.2011.09.018
Pathological Correlates of Late Drug-Eluting Stent Thrombosis: Strut Coverage as a Marker of Endothelialization, Circulation, vol.115, issue.18, pp.2435-2441, 2007. ,
DOI : 10.1161/CIRCULATIONAHA.107.693739
The Taxus??? drug-eluting stent: A new paradigm in controlled drug delivery, Advanced Drug Delivery Reviews, vol.58, issue.3, pp.412-436, 2006. ,
DOI : 10.1016/j.addr.2006.01.023
Modelling drug-eluting stents, Mathematical Medicine and Biology, vol.28, issue.1, p.20413417, 2011. ,
DOI : 10.1093/imammb/dqq003
The range of optimal concentration and mechanisms of paclitaxel in radio-enhancement in gastrointestinal cancer cell lines, Cancer Chemotherapy and Pharmacology, vol.57, issue.6, pp.733-742, 2006. ,
DOI : 10.1007/s00280-006-0327-1
Paclitaxel Inhibits Arterial Smooth Muscle Cell Proliferation and Migration In Vitro and In Vivo Using Local Drug Delivery, Circulation, vol.96, issue.2, pp.636-645, 1997. ,
DOI : 10.1161/01.CIR.96.2.636
Rapamycin inhibits vascular smooth muscle cell migration., Journal of Clinical Investigation, vol.98, issue.10, pp.2277-2283, 1996. ,
DOI : 10.1172/JCI119038
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC507677
Effects of Tacrolimus or Sirolimus on Proliferation of Vascular Smooth Muscle and Endothelial Cells, Journal of Cardiovascular Pharmacology, vol.48, issue.6, pp.286-292, 2006. ,
DOI : 10.1097/01.fjc.0000248233.22570.8b
Role for p27Kip1 in Vascular Smooth Muscle Cell Migration, Circulation, vol.103, issue.24, pp.2967-2972, 2001. ,
DOI : 10.1161/01.CIR.103.24.2967
Pathological Perspective of Drug-Eluting Stent Thrombosis, Thrombosis, vol.5, issue.1, pp.1-8, 2012. ,
DOI : 10.1016/S1054-8807(03)00132-7
Comparative characterization of cellular and molecular anti-restenotic profiles of paclitaxel and sirolimus. Implications for local drug delivery, Thrombosis and Haemostasis, vol.97, pp.1003-1012, 2007. ,
DOI : 10.1160/TH06-10-0586
Pathobiologic responses to stenting, The American Journal of Cardiology, vol.81, issue.98, pp.4-6, 1998. ,
Twenty-eight-day efficacy and phamacokinetics of the sirolimus-eluting stent, Coronary Artery Disease, vol.13, issue.3, pp.183-188, 2002. ,
DOI : 10.1097/00019501-200205000-00008
Vascular Smooth Muscle Cell Proliferation in Restenosis, Circulation: Cardiovascular Interventions, vol.4, issue.1, pp.104-111, 2011. ,
DOI : 10.1161/CIRCINTERVENTIONS.110.957332
Mechanisms of controlled drug release from drug-eluting stents, Advanced Drug Delivery Reviews, vol.58, issue.3, pp.387-401, 2006. ,
DOI : 10.1016/j.addr.2006.01.016
A rigorous framework for optimization of expensive functions by surrogates, Structural Optimization, vol.16, issue.1, pp.1-13, 1999. ,
DOI : 10.1007/BF01197708
A statistical approach to some basic mine valuation problems on the witwatersrand, Journal of the Chemical, Metallurgical and Mining Society of South Africa, vol.52, pp.119-139, 1951. ,
Principles of geostatistics, Economic Geology, vol.58, issue.8, pp.1246-1266, 1963. ,
DOI : 10.2113/gsecongeo.58.8.1246
Engineering design via surrogate modelling a practical guide, 2008. ,
Optimal Aeroacoustic Shape Design Using the Surrogate Management Framework, Optimization and Engineering, vol.5, issue.2, pp.235-262, 2004. ,
DOI : 10.1023/B:OPTE.0000033376.89159.65
Trailing-edge noise reduction using derivative-free optimization and large-eddy simulation, Journal of Fluid Mechanics, vol.572, pp.13-23, 2007. ,
DOI : 10.1017/S0022112006003235
A computational framework for derivative-free optimization of cardiovascular geometries, Computer Methods in Applied Mechanics and Engineering, vol.197, issue.21-24, pp.1890-1905, 2008. ,
DOI : 10.1016/j.cma.2007.12.009
Constrained optimization of an idealized Y-shaped baffle for the Fontan surgery at rest and exercise, Computer Methods in Applied Mechanics and Engineering, vol.199, issue.33-36, pp.2135-2149, 2010. ,
DOI : 10.1016/j.cma.2010.03.012
A brief description of natural neighbor interpolation Wiley series in probability and mathematical statistics, Interpreting multivariate data, pp.21-36, 1981. ,
Paclitaxel-induced Arterial Wall Toxicity and Inflammation: Tissue Uptake in Various Dose Densities in a Minipig Model, Journal of Vascular and Interventional Radiology, vol.21, issue.8, pp.1262-1270, 2010. ,
DOI : 10.1016/j.jvir.2010.02.020
Stents as a platform for drug delivery, Expert Opinion on Drug Delivery, vol.104, issue.6, p.21548713, 2011. ,
DOI : 10.1016/j.jcin.2008.07.003
Current and future drug-eluting coronary stent technology, Expert Review of Cardiovascular Therapy, vol.9, issue.4, pp.485-503, 2011. ,
DOI : 10.1586/erc.11.5
Drug-eluting stents show delayed healing: paclitaxel more pronounced than sirolimus, European Heart Journal, vol.28, issue.8, pp.974-979, 2007. ,
DOI : 10.1093/eurheartj/ehm064
Implantation of paclitaxel-eluting stent impairs the vascular compliance of arteries in porcine coronary stenting model, Atherosclerosis, vol.202, issue.1, pp.144-151, 2009. ,
DOI : 10.1016/j.atherosclerosis.2008.04.039
Pathological Analysis of Local Delivery of Paclitaxel Via a Polymer-Coated Stent, Circulation, vol.104, issue.4, pp.473-479, 2001. ,
DOI : 10.1161/hc3001.092037
Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content., Heart, vol.69, issue.5, pp.377-381, 1993. ,
DOI : 10.1136/hrt.69.5.377
Decreased vascular smooth muscle cell density in medial degeneration of human abdominal aortic aneurysms, The American Journal of Pathology, vol.150, pp.993-1007, 1997. ,
Drug-Coated Balloons for the Prevention of Vascular Restenosis, Circulation, vol.121, issue.24, pp.2672-2680, 2010. ,
DOI : 10.1161/CIRCULATIONAHA.110.936922
Choice of drug-eluting stent???evidence-based or empirical, Journal of Indian College of Cardiology, vol.2, issue.1, pp.22-28, 2012. ,
DOI : 10.1016/S1561-8811(12)80005-8
Evaluation of neointimal coverage and apposition with various drug-eluting stents over 12months after implantation by optical coherence tomography, International Journal of Cardiology, vol.162, issue.3, pp.166-171, 2013. ,
DOI : 10.1016/j.ijcard.2011.05.076
Coronary Stents, Journal of the American College of Cardiology, vol.56, issue.10, pp.43-78, 2010. ,
DOI : 10.1016/j.jacc.2010.06.008
627?drug-eluting stents, Comprehensive Biomaterials, vol.6, pp.427-448, 2011. ,
Sirolimus-eluting coronary stents: a review, Vascular Health and Risk Management, vol.3, issue.2, pp.191-201, 2007. ,
DOI : 10.2147/vhrm.2007.3.2.191
2-Year Follow-Up of a Randomized Controlled Trial of Everolimus- and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice, Journal of the American College of Cardiology, vol.58, issue.1, pp.11-18, 2011. ,
DOI : 10.1016/j.jacc.2011.02.023
Randomized Comparison of Everolimus- and Paclitaxel-Eluting Stents, Journal of the American College of Cardiology, vol.58, issue.1, pp.19-25, 2011. ,
DOI : 10.1016/j.jacc.2011.02.022
Drug-eluting balloons for restenosis after stent implantation, The Lancet, vol.381, issue.9865, pp.431-433, 2013. ,
DOI : 10.1016/S0140-6736(12)62120-5
Paclitaxel coated balloons, the time for awareness has come, International Journal of Cardiology, vol.164, issue.1, p.22658568, 2013. ,
DOI : 10.1016/j.ijcard.2012.05.037
Treatment of Coronary In-Stent Restenosis with a Paclitaxel-Coated Balloon Catheter, New England Journal of Medicine, vol.355, issue.20, pp.2113-2124, 2006. ,
DOI : 10.1056/NEJMoa061254